AU2746292A - Asthma and other allergies cure - Google Patents

Description

_i

P/00/008a 12/11191 Section 29(1) Regulation 3.1 (2) AUSTRALIA

PatentsAct 1990

NOTICE OF ENTITLEMENT (To be filed before acceptance)

I/W e .7 .Z of 7

being the applicant in respect of Application No. state the following:-

Part I Must be completed FOR ALL APPLICATIONS.

The person(s) nominated for the grant of the patent: *is 'ae the actual inventor(s) or *has entitlem ent from the actual

(eg by assignment, by mesne assignment, as legal representative of etc)

Part 2 Must be completed IF THE APPLICATION IS ASSOCIATED with one or more PROVISIONAL APPLICATIONS.

The person nominated for the grant of the patent: *is the applicant(s) of the provisional application(s) listed on the patent reqtest form

or has entitlement to make a request under Section 113 in relation to the provisional application(s) listed on Sp aten t re qu est form i (eg by assignment, by agreement, etc)

(Signature) (Date) (If the applicant is a Company or other legal entity, also indicate the name and standing of the authorized signatory.)

Omit/Delete if not appropriate

Note: Use form P/00/008b where details for PCT, convention priority, microorganism deposit, additional or divisional applcation, are required.

Ill~_m~ ~__XX1

Ililtilll 11111 11111 11111 11111 11111 till AU9227411111 (12) PATENT ABSTRACT (11) Document No. AU-A-27462/92 (19) AUSTRALIAN PATENT OFFICE (54) Title ASTHMA AND OTHER ALLERGIES CURE International Patent Classification(s) 5 (51) A61K 033/14 A61K 009/72 (21) Application No.: 27462/92 (22) Application Date: 29.10.92 Priority Data (31) Number (32) Date (33) Country PK9196 30.10.91 AU AUSTRALIA (43) Publication Date 06.05.93 (71) Applicant(s) KENNETH ROY HANSON (72) Inventor(s) KENNETH ROY HANSON (57) A simple all natural product that will alleviate the symptoms and problems

associated with asthma and other allergies."

ASTHMA AND OTHER ALLERGIES CURE

Place 50 grammes of salt (Sodium Chloride NaCI) containing from 25 to

milligrammes of Iodine I, per kilo in 500 millilitres of water. Stir until

dissolved.

Place solution in a fine mist sprayer.

Method:

Expel all air from lungs without causing discomfort. The while inhaling

through the mouth, spray solution in to open mouth. Spray container nozzle

to be held 20cm from mouth and to be set for a fine mist spray.

Each breath to be a maximum amount without discomfort, while inhaling

spray. (Possibly more than one squeeze on spray device will be necessary

during the intake of breath.)

Exhale slowly.

ii~~l~ I~e~a~

(11)27462/92 -2-

Then take three normal breaths.

Repeat six times per session.

Treatment to be administered twice daily w'th twelve hours between doses for

three days.

P/00/01i1 2815M9 Regulation 3.2 AUSTRALIA

PatentsAct 1990

ORIGINAL COMPLETE SPECIFICATION STANDARD PATENT

Invention Title: 7+ 4!i 5.f z

%The following statement is a full description of this invention, including the best :*method of performing it known to me:- Z

I. I.

T he c laims def i ning t he i nv ent ion are as follows

I

q*

(Name of Applicant) (Date) (BLOCK LETTERS)

Note: Ifthere is insufficient space above to type the statement of claim, do not use this sheet, but use separate sheets of paper beginning with the words The claims defining the invention are as follows: and ending with the date and the name of the applicant in block letters.

This invention relates to the cure of asthma, eliminating the need for continuous use of expensive medications.

005 There are many medications available for the relief of the asthma symptoms, but these are for relief only, and do not provide a cure.

010 Medications available are potentially dangerous and doctors prescribing current asthma medications, warn patients of the dangers

015 of exceeding the recommended doses. These include nausea,

giddiness, weakness and the tremors.

oo 020 These problems are overcome by the invention, as it consists of natural o 0R

ingredients only; is a once only course of inhalant, taken morning and night for 0 o0 three days, effecting the cure.

S 0 2 This does not require any follow up medication.

030 This invention is prepared in liquid form and is administered in a fine spray.

Any device capable of delivering a fine mist spray is adequate to administer solution to the patient. 035 With a recommended "dose" of lOml of solution propelled by compressed air

from a hand operated mist sprayer per breath, e.g. 60ml per session twice 040 daily, the cost of administering the cure is substantially lower than the current

CFC propelled asthma reliefs currently being prescribed.

Claims (1)

1. "The claims defining the invention are as follows:-

   A simple all natural product that will alleviate the symptoms and problems 005 associated with asthma and other allergies."

   ASTHMA AND OTHER ALLERGIES CURE 010

   Place 50 grammes of salt (Sodium Chloride NaCI) containing from 25 to

   milligrammes of Iodine I, per kilo in 500 millilitres of water. Stir until 015 dissolved.

   Place solution in a fine mist sprayer. 020

   Method:

   025 Expel all air from lungs without causing discomfort. The while inhaling through the mouth, spray solution in to open mouth. Spray container nozzle

   to be held 20cm from mouth and to be set for a fine mist spray. 030

   Each breath to be a maximum amount without discomfort, while inhaling

   spray. (Possibly more than one squeeze on spray device will be necessary 035 during the intake of breath.)

   Exhale slowly. 040 Then take three normal breaths.

   045 Repeat six times per session.

   Treatment to be administered twice daily with twelve hours between doses for

   050 three days. i

   KENNETH ROY HANSON (Name of Applicant) (Date) (BLOCK LETTERS)

   ABSTRACT

   A cure for asthma based on totally naturally occurring products found in the normal household kitchen.

   A known concentration of Sodium Chloride NaCI (normal household lodised Salt) dissolved in water and administered in a simple hand operated pump spray.

   Totally environmentally safe.

   Contains NO CFC's unlike most other asthma treatments currently on the market.

   I